CLINICAL_TRIALS
withdrawal
· 2018-07-11
Clinical Trial Update: Study Evaluating Gerilimzumab´s Safety/Efficacy for Patients MTX or TNFα Antagonist Failed in Rheumatoid Arthritis [Phase 2]
Summary
A Phase 2 clinical trial evaluating the safety and efficacy of Gerilimzumab in rheumatoid arthritis patients who failed methotrexate or TNF-alpha antagonists ha…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bird Rock Bio, Inc. | Conditions: Rheumatoid Arthritis | Phase 2 | Status: WITHDRAWN